Finally, rosuvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, can alleviate the consequences of diabetes in rat hearts through the downregulation of NLRP3 (32). Here, NLRP3 is linked to diabetes mellitus.